Fig. 5From: Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancerEndoglin immunostaining in colon and rectal cancer patient samples. One representative image of non-tumoral and tumoral zone from different patients differentiating between low/medium levels of sEng or high levels of sEng in plasma of these patients. Tumoral area (T) versus non-tumoral (NT) zone from colon (a) and rectal (b) cancer. Magnification × 20 and × 40Back to article page